Skip to main content
Top
Published in: Journal of Bone and Mineral Metabolism 2/2021

01-03-2021 | Computed Tomography | Original Article

Effect of periosteal reaction in medication-related osteonecrosis of the jaw on treatment outcome after surgery

Authors: Sakiko Soutome, Souichi Yanamoto, Misa Sumi, Saki Hayashida, Yuka Kojima, Shunsuke Sawada, Satoshi Rokutanda, Hiroshi Iwai, Toshiyuki Saito, Masahiro Umeda

Published in: Journal of Bone and Mineral Metabolism | Issue 2/2021

Login to get access

Abstract

Introduction

Surgical treatment in patients with medication-related osteonecrosis of the jaw (MRONJ) is superior to conservative treatment. However, treatment outcome in patients with periosteal reaction (PR) was significantly poorer than that of those without PR. The purpose of this retrospective study was to analyze the pathophysiology and clinical significance of PR in MRONJ.

Materials and methods

Out of 181 patients with MRONJ undergoing surgery, 38 patients with PR were enrolled in the study. CT examinations, histological examinations, and bacteriological examinations using real-time polymerase chain reaction were performed, and the relationship among the opted surgical method, CT findings, and treatment outcome was investigated.

Results

The pattern of PR was classified into three types: type 1, new bone is formed parallel to the mandible, and no gap was evident between the mandible and new bone; type 2, new bone is formed parallel to the mandible, and a gap was evident between them; type 3, an irregular shape. Histological examinations revealed inflammatory tissue in the area visualized as a gap on CT. Bacteriological examination showed the presence of bacteria in the type 2 or type 3 PR. Complete cure was observed in 21 of 38 (55.3%) patients, which was lower than the cure rate of 73.4% in 143 patients without PR. The cure rate was significantly lower in cases with type 3 PR or with persistent osteolysis.

Conclusions

It seems that complete resection of both osteolytic area and type 3 PR is necessary to obtain complete healing in patients undergoing marginal mandibulectomy.
Literature
1.
go back to reference Hayashida S, Soutome S, Yanamoto S, Fujita S, Hasegawa T, Komori T, Miyamoto H, Shibuya Y, Ueda N, Kirita T, Nakahara H, Shinohara M, Umeda M (2017) Evaluation of the treatment strategies for medication-related osteonecrosis of the jaws (MRONJ) and the factors affecting treatment outcome: a multicenter retrospective study with propensity score matching analysis. J Bone Miner Res 32:2022–2029CrossRef Hayashida S, Soutome S, Yanamoto S, Fujita S, Hasegawa T, Komori T, Miyamoto H, Shibuya Y, Ueda N, Kirita T, Nakahara H, Shinohara M, Umeda M (2017) Evaluation of the treatment strategies for medication-related osteonecrosis of the jaws (MRONJ) and the factors affecting treatment outcome: a multicenter retrospective study with propensity score matching analysis. J Bone Miner Res 32:2022–2029CrossRef
2.
go back to reference Kojima Y, Kawaoka Y, Sawada S, Hayashida S, Okuyama K, Yutori H, Kawakita A, Ishida S, Soutome S, Yanamoto S, Umeda M, Iwai H (2019) Clinical significance of periosteal reaction as a predictive factor for treatment outcome of medication-related osteonecrosis of the jaw. J Bone Miner Metab 37:913–919CrossRef Kojima Y, Kawaoka Y, Sawada S, Hayashida S, Okuyama K, Yutori H, Kawakita A, Ishida S, Soutome S, Yanamoto S, Umeda M, Iwai H (2019) Clinical significance of periosteal reaction as a predictive factor for treatment outcome of medication-related osteonecrosis of the jaw. J Bone Miner Metab 37:913–919CrossRef
3.
go back to reference Tsuda S, Soutome S, Hayashida S, Funahara M, Yanamto S, Umeda M (2020) Topical povidone iodine inhibits bacterial growth in the oral cavity of patients on mechanical ventilation: a randomized controlled study. BMC Oral Health 20:62CrossRef Tsuda S, Soutome S, Hayashida S, Funahara M, Yanamto S, Umeda M (2020) Topical povidone iodine inhibits bacterial growth in the oral cavity of patients on mechanical ventilation: a randomized controlled study. BMC Oral Health 20:62CrossRef
4.
go back to reference Ruggiero SL, DodsonTB FJ, Goodday R, Aghaloo T, Mehrotra B, O'Ryan F, American Association of Oral, and Maxillofacial Surgeons (2014) American association of oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the jaw-2014 update. J Oral Maxillofac Surg 72:1938–1956CrossRef Ruggiero SL, DodsonTB FJ, Goodday R, Aghaloo T, Mehrotra B, O'Ryan F, American Association of Oral, and Maxillofacial Surgeons (2014) American association of oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the jaw-2014 update. J Oral Maxillofac Surg 72:1938–1956CrossRef
5.
go back to reference Ida M, Tetsumura A, Kurabayashi T, Sasaki T (1997) Periosteal new bone formation in the jaws. A computed tomographic study. Dentomaxillofac Radiol 26:169–176CrossRef Ida M, Tetsumura A, Kurabayashi T, Sasaki T (1997) Periosteal new bone formation in the jaws. A computed tomographic study. Dentomaxillofac Radiol 26:169–176CrossRef
6.
go back to reference Suei Y (2013) Radiographic findings of bisphosphonate-related osteomyelitis of the jaw: investigation of the diagnostic points by comparison with radiation osteomyelitis, suppurative osteomyelitis, and diffuse sclerosing osteomyelitis. Oral Radiol 29:121–134CrossRef Suei Y (2013) Radiographic findings of bisphosphonate-related osteomyelitis of the jaw: investigation of the diagnostic points by comparison with radiation osteomyelitis, suppurative osteomyelitis, and diffuse sclerosing osteomyelitis. Oral Radiol 29:121–134CrossRef
Metadata
Title
Effect of periosteal reaction in medication-related osteonecrosis of the jaw on treatment outcome after surgery
Authors
Sakiko Soutome
Souichi Yanamoto
Misa Sumi
Saki Hayashida
Yuka Kojima
Shunsuke Sawada
Satoshi Rokutanda
Hiroshi Iwai
Toshiyuki Saito
Masahiro Umeda
Publication date
01-03-2021
Publisher
Springer Singapore
Published in
Journal of Bone and Mineral Metabolism / Issue 2/2021
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-020-01154-6

Other articles of this Issue 2/2021

Journal of Bone and Mineral Metabolism 2/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.